Suppr超能文献

HT-29人结肠腺癌细胞系对肿瘤的体内延迟排斥反应及对迟发型超敏反应的抑制作用。

In vivo delayed rejection of tumors and inhibition of delayed-type hypersensitivity by HT-29 human colonic adenocarcinoma cell line.

作者信息

Pommier G J, Garrouste F L, Bettetini D, Culouscou J M, Remacle-Bonnet M M

出版信息

Cancer Immunol Immunother. 1987;24(3):225-30. doi: 10.1007/BF00205634.

DOI:10.1007/BF00205634
PMID:3594485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11038160/
Abstract

Products secreted by HT-29 human colonic adenocarcinoma cells (DMEM-HT-29) mediated strong suppressive activity of in vitro lymphoproliferative responses to several mitogens. In vivo administration of DMEM-HT-29 both inhibited the afferent limb of delayed-type hypersensitivity against the Mc FiFi2(s) syngeneic fibrosarcoma and delayed the rejection of these tumor cells by immunized animals. Transfer experiments prior or after cell fractionation did not demonstrate suppressor cells induced by DMEM-HT-29. This suggests that DMEM-HT-29 produces its effect by directly interacting with macrophage and/or T cells at the sensitization stage of the antitumor immune response.

摘要

HT-29人结肠腺癌细胞（DMEM-HT-29）分泌的产物介导了对多种有丝分裂原的体外淋巴细胞增殖反应的强烈抑制活性。体内给予DMEM-HT-29既抑制了对同基因Mc FiFi2(s)纤维肉瘤的迟发型超敏反应的传入支，又延迟了免疫动物对这些肿瘤细胞的排斥。细胞分级分离之前或之后的转移实验均未证明DMEM-HT-29诱导出抑制细胞。这表明DMEM-HT-29在抗肿瘤免疫反应的致敏阶段通过与巨噬细胞和/或T细胞直接相互作用发挥其效应。

相似文献

1
In vivo delayed rejection of tumors and inhibition of delayed-type hypersensitivity by HT-29 human colonic adenocarcinoma cell line.HT-29人结肠腺癌细胞系对肿瘤的体内延迟排斥反应及对迟发型超敏反应的抑制作用。
Cancer Immunol Immunother. 1987;24(3):225-30. doi: 10.1007/BF00205634.
2
Rat adenocarcinoma 13762 expresses tumor rejection antigens but tumor-bearing animals exhibit tumor-specific immunosuppression.大鼠腺癌13762表达肿瘤排斥抗原，但荷瘤动物表现出肿瘤特异性免疫抑制。
Clin Immunol Immunopathol. 1993 Nov;69(2):223-33. doi: 10.1006/clin.1993.1173.
3
Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.重组癌胚抗原-痘苗病毒疫苗诱导的抗肿瘤活性和免疫反应
J Natl Cancer Inst. 1992 Jul 15;84(14):1084-91. doi: 10.1093/jnci/84.14.1084.
4
Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.两种同基因肿瘤中肿瘤免疫小鼠和荷瘤小鼠的效应表型及抗肿瘤免疫反应机制
Cell Immunol. 1991 Oct 1;137(1):200-15. doi: 10.1016/0008-8749(91)90069-n.
5
In vitro approaches to the mechanism of cell-mediated immune reactions.细胞介导免疫反应机制的体外研究方法。
Adv Immunol. 1971;13:101-208. doi: 10.1016/s0065-2776(08)60184-4.
6
Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.通过对同基因大鼠粗病毒诱导的淋巴瘤的二次免疫反应在体外产生的细胞进行系统性肿瘤免疫的被动转移。
J Immunol. 1977 Jan;118(1):122-8.
7
Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.同基因小鼠中A/Ph.MC.S1肿瘤移植排斥的机制。
Gan. 1983 Oct;74(5):712-22.
8
Introduction of cellular immunity to a chemically altered tumor antigen.将细胞免疫引入化学改变的肿瘤抗原
J Immunol. 1973 Dec;111(6):1800-3.
9
Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.癌症疫苗：单表位抗独特型疫苗与多表位抗原疫苗
Cancer Immunol Immunother. 2000 Jun;49(3):123-32. doi: 10.1007/s002620050611.
10
Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.对小鼠体内已形成的肿瘤，全身性给予细胞白细胞介素-10可诱导产生有效、特异且持久的免疫反应。
J Immunol. 1996 Jul 1;157(1):231-8.

引用本文的文献

1
Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines.体外培养的肿瘤细胞系无血清上清液对淋巴因子激活的杀伤（LAK）细胞生成的抑制作用。
Br J Cancer. 1989 Apr;59(4):515-21. doi: 10.1038/bjc.1989.106.
2
Combination of interferons and cytostatic drugs for treatment of advanced colorectal cancer.干扰素与细胞抑制药物联合治疗晚期结直肠癌
J Cancer Res Clin Oncol. 1991;117 Suppl 4(Suppl 4):S214-20. doi: 10.1007/BF01613230.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Characterization of an inhibitor of cell division released in tumour cell cultures.肿瘤细胞培养物中释放的一种细胞分裂抑制剂的特性分析。
Clin Exp Immunol. 1980 Sep;41(3):487-96.
3
Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation.巨噬细胞介导的抑制作用。I. 过氧化氢和前列腺素参与抑制小鼠淋巴细胞增殖的证据。
J Immunol. 1980 Feb;124(2):983-8.
4
An inhibitor of lymphocyte proliferation produced by a human colonic adenocarcinoma cell line in culture.一种由人结肠腺癌细胞系在培养过程中产生的淋巴细胞增殖抑制剂。
Cancer Res. 1980 Jan;40(1):29-35.
5
Explant culture of human colon.人结肠外植体培养
Methods Cell Biol. 1980;21B:385-401. doi: 10.1016/s0091-679x(08)60694-9.
6
Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.单核细胞和多形核白细胞在体外对自然杀伤的抑制作用：对氧反应性代谢产物的需求。
J Clin Invest. 1982 Apr;69(4):876-88. doi: 10.1172/jci110527.
7
Murine alveolar macrophage-mediated lymphocyte cytostasis: kinetics and mechanisms.小鼠肺泡巨噬细胞介导的淋巴细胞细胞停滞：动力学与机制
Cell Immunol. 1982 Nov 1;73(2):264-74. doi: 10.1016/0008-8749(82)90454-3.
8
Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.用环磷酰胺进行化学免疫疗法并过继转移同基因Lyt-1+2-淋巴细胞根除播散性小鼠白血病
J Exp Med. 1981 Sep 1;154(3):952-63. doi: 10.1084/jem.154.3.952.
9
Immunologic reactivity of lymphoid cells in tumors.肿瘤中淋巴细胞的免疫反应性。
Contemp Top Immunobiol. 1980;10:61-78. doi: 10.1007/978-1-4684-3677-8_3.
10
Immunosuppression associated with SJL/J murine lymphoma. II. Characterization of a plasma suppressor factor in tumor-bearing mice.与SJL/J小鼠淋巴瘤相关的免疫抑制。II. 荷瘤小鼠血浆抑制因子的特性
J Natl Cancer Inst. 1981 Dec;67(6):1277-82.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验